The nine-valent cervical cancer vaccine is for the prevention of cervical cancer and precancerous lesions, and is also effective in preventing warts.
The human papillomavirus is known as the HPV virus, and persistent infection with high-risk HPV viruses may lead to cervical cancer. Cervical cancer vaccination can play a role in blocking HPV infection, thus preventing cervical cancer.
The nine-valent cervical cancer vaccine can effectively prevent the infection of HPV types 6, 11, 16, 18, 31, 33, 45, 52, 58, at present, it is the cervical cancer vaccine that covers the most subtypes of HPV virus. And as warts are mostly due to HPV types 6 and 11 infection, it can also prevent warts.
The best people to receive the nine-valent cervical cancer vaccine are women between the ages of 16 and 26. It is usually given in three injections within six months. The first injection can be given at a time of your choosing, the second injection is given two months later, and the third injection is given after another four months. In order not to affect the effect of the vaccine, it should be given on time. It is recommended to consult a specialized doctor for details.